Top Markets
Coin of the day
Life Stem Genetics Inc. Life Stem Genetics Inc.

Life Stem Genetics Inc.

LIFS
Rang in Aktien #42117
Life Stem Genetics Inc., an enterprise currently in its development phase, is... Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung diseases, as well as hyperbaric oxygen therapy. Life Stem Genetics Inc. maintains a strategic collaborative agreement with American CryoStem Corporation. This company was founded in 2012 and operates from its base in Beverly Hills, California.
Aktienkurs
$0.0001
Marktkapitalisierung
$4.58K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Life Stem Genetics Inc. (LIFS)

Kategorie

EPS für Life Stem Genetics Inc. (LIFS)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Life Stem Genetics Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Life Stem Genetics Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$17.32 -
US
$27.74 -
NL
- -
CH
$13.70 -
BE
- -
KR